North Carolina Wellness News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Carolina Wellness News.

Press releases published on April 27, 2026

Apr. 27, 2026

Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer

Indeterminate GlobeNewswire

Apr. 27, 2026

Opus Genetics to Participate in Leading Medical Conferences in May 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Real-World Data on EXPAREL® Shows Reduced Opioid Use and Lower Total Medical Costs in Medicare Patients Undergoing Total Hip Arthroplasty

Indeterminate GlobeNewswire

Apr. 27, 2026

LifeMD to Report First Quarter 2026 Financial Results on May 6

Indeterminate GlobeNewswire

Apr. 27, 2026

Humacyte to Host Virtual KOL Event to Discuss ATEV for Arteriovenous (AV) Access for Hemodialysis Patients on April 28, 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury

Indeterminate GlobeNewswire

Apr. 27, 2026

Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

Indeterminate GlobeNewswire

Apr. 27, 2026

PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01

Indeterminate GlobeNewswire

Apr. 27, 2026

Solésence, Inc. Announces Appointment of New Independent Director

Indeterminate GlobeNewswire

Apr. 27, 2026

Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress

Indeterminate GlobeNewswire

Apr. 27, 2026

Arcutis Submits Supplemental New Drug Application to the FDA for ZORYVE® (roflumilast) Cream 0.05% to Expand Indication for Treatment of Atopic Dermatitis to Infants Down to 3 Months

Indeterminate GlobeNewswire

Apr. 27, 2026

Belite Bio Announces Oral Presentation at the Retinal Therapeutics Innovation Summit

Indeterminate GlobeNewswire

Apr. 27, 2026

SBC Medical Announces Full-Scale Rollout of Aesthetic Healthcare-Focused Interpretation App "Talk Bridge" Across All Shonan Beauty Clinic Locations

Indeterminate GlobeNewswire

Apr. 27, 2026

Vystar Plans Dividend Spin Off of RXAIR and Related Brands Following R3alm, Inc. Transaction

Indeterminate GlobeNewswire

Apr. 27, 2026

Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation

Indeterminate GlobeNewswire

Apr. 27, 2026

BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Indeterminate GlobeNewswire

Apr. 27, 2026

Tovecimig Demonstrates Statistically Significant Benefit in COMPANION-002 Randomized Phase 2/3 Study in Patients with Biliary Tract Cancer

Indeterminate GlobeNewswire

Apr. 27, 2026

NIMA’s Next-Gen Portable Gluten Sensor Wins Gold Stevie® Award for Achievement in Product Innovation

Indeterminate GlobeNewswire

Apr. 27, 2026

Medicus Pharma CEO meets with lawmakers on Energy & Commerce Committee on Capitol Hill

Indeterminate GlobeNewswire